Rethinking the Appraisal and Approval of Drugs for Fracture Prevention

• Autori principali: Juan Erviti (Autore), Javier Gorricho (Autore), Luis C. Saiz (Autore), Thomas Perry (Autore), James M. Wright (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2017-05-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background: In January 2014, the EMA's Pharmacovigilance Risk Assessment Committee recommended that strontium ranelate no longer be used for osteoporosis. However, EMA's Committee for Medicinal Products for Human Use decided to restrict its use rather than ban it. Starting from this fact,...